Hepatitis B: Treatment strategies for currently available drugs

被引：0
|
作者：
Robert P. Perrillo
机构：
[1] Ochsner Clinic,Section of Gastroenterology and Hepatology
来源：
Current Hepatitis Reports | 2003年 / 2卷 / 2期
关键词：
Chronic Hepatitis; Lamivudine; Virologic Response; Nucleoside Analogue; Adefovir;
D O I：
10.1007/s11901-003-0022-1
中图分类号：
学科分类号：
摘要：
There are three licensed drugs for chronic hepatitis B at the current time: interferon alpha, and the nucleoside analogues, lamivudine and adefovir. The benefits as well as limitations of each of these agents are described in this article. Preliminary studies suggest that the combination of interferon and lamivudine is associated with an enhanced rate of virologic response when compared with either agent alone.
引用
收藏
页码：63 / 70
页数：7
相关论文
共 50 条
  • [11] Treatment of chronic hepatitis B virus infection in children
    Brumbaugh D.E.
    Sokol R.J.
    Current Hepatitis Reports, 2009, 8 (3) : 96 - 102
  • [12] Current Management Strategies for Hepatitis B in the Elderly
    Philippe Merle
    Christian Trépo
    Fabien Zoulim
    Drugs & Aging, 2001, 18 : 725 - 735
  • [13] Treatment of acute hepatitis b with nucleoside and/or nucleotide analogues
    Te H.S.
    Current Hepatitis Reports, 2010, 9 (2) : 119 - 123
  • [14] Emerging drugs for hepatitis B
    Zoulim, Fabien
    EXPERT OPINION ON EMERGING DRUGS, 2007, 12 (02) : 199 - 217
  • [15] Treatment of chronic hepatitis B
    Stephanie D. Straley
    Norah A. Terrault
    Current Hepatitis Reports, 2003, 2 (2) : 49 - 59
  • [16] Drugs in Development for Hepatitis B
    Maria Buti
    Rafael Esteban
    Drugs, 2005, 65 : 1451 - 1460
  • [17] Treatment of antiviral therapy for chronic hepatitis B: A disease in evolution
    Sreekala Satheesh
    Robert P. Perrillo
    Current Hepatitis Reports, 2005, 4 (1) : 14 - 20
  • [18] Treatment of chronic hepatitis B: new antiviral therapies.
    Yao F.
    Gish R.G.
    Current Gastroenterology Reports, 1999, 1 (1) : 20 - 26
  • [19] Telbivudine for the treatment of hepatitis B disease
    Tsunoda, Shirley M.
    Hassanein, Tarek
    FUTURE VIROLOGY, 2008, 3 (06) : 517 - 527
  • [20] A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B
    D. Eldon Spackman
    David L. Veenstra
    PharmacoEconomics, 2008, 26 : 937 - 949
12345